Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
BDC Venture Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
BDC Venture Capital

BDC Venture Capital

Operating

BDC Venture Capital: A leading Canadian investor, fostering growth in tech-based SMEs since 1975.

Location
Montreal, Quebec, CA
Founded
1975
Firm
Compare
Portfolio
Employees
News
Website

Investments

Graphite Innovation and Technologies
Graphite Innovation and Technologies

Total Raised

$14.9M

Rounds

4

Series A$10MApril 2023
Kepler Communications
Kepler Communications
Series C

Total Raised

$181.9M

Rounds

9

Series C$92MApril 2023
Acerta
Acerta

Total Raised

$21.3M

Rounds

5

Series B$10.4MNovember 2022
Periculum
Periculum

Total Raised

$1.7M

Rounds

6

Seed$800kMay 2022
SkyWatch
SkyWatch
Series B

Total Raised

$32.1M

Rounds

11

Series B$21MJune 2021
Expeto
Expeto

Total Raised

$25.9M

Rounds

6

Convertible NoteApril 2021
Series A$10MApril 2021
Cinchy
Cinchy
Series B

Total Raised

$27.6M

Rounds

8

Series A$10MMay 2020
Monteris Medical
Monteris Medical

Total Raised

$216.1M

Rounds

18

Series C$26.6MJune 2017
Series B$30MNovember 2014
Series Unknown$8.3MOctober 2013
Next Canada
Next Canada

Total Raised

$8.8M

Rounds

3

Series Unknown$5.2MJanuary 2017
Pitstop
Pitstop

Total Raised

$6.2M

Rounds

7

Pre-Seed$750kJuly 2016
Validere
Validere
Series B

Total Raised

$81.2M

Rounds

6

Seed$1MApril 2016
Sonder
Sonder
Public

Total Raised

$839.5M

Rounds

12

Series A$11.1MFebruary 2016
Seed$6.5MFebruary 2015
Hortau
Hortau

Total Raised

$68.9M

Rounds

12

Series C$10MFebruary 2016
Series Unknown$5MJune 2015
Garage Capital
Garage Capital

Total Raised

$50M

Rounds

2

SeedJanuary 2016
Minuum
Minuum
Acquired

Total Raised

$500k

Rounds

2

Seed$500kFebruary 2014
Provender
Provender

Total Raised

$1.4M

Rounds

5

Seed$150kAugust 2013
BrandProject
BrandProject

Total Raised

$12M

Rounds

1

Series Unknown$12MAugust 2013
FounderFuel
FounderFuel

Total Raised

$6M

Rounds

2

Convertible Note$6MApril 2012
Osprey Pharmaceuticals USA
Osprey Pharmaceuticals USA

Total Raised

$29.7M

Rounds

5

Series A$11MSeptember 2008
Tranzyme
Tranzyme
Acquired

Total Raised

$20M

Rounds

2

Series Unknown$20MNovember 2007